The announcement was made during market hours today.
Solara Active Pharma Sciences engaged in the business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients.
The company's consolidated net profit surged to Rs 3.77 crore in the quarter ended March 2023 as against Rs 1.88 crore during the previous quarter ended March 2022. Sales rose 5.49% to Rs 380.62 crore in Q4 FY23 over Q4 FY22.
The scrip added 0.70% to currently trade at Rs 383.20 on the BSE.
|